Trastuzumab in Treating Women With HER2-Positive Early Breast Cancer
Clinical trial NCT00712140 · UNKNOWN
Trial details
- NCT number
- NCT00712140
- Sponsor
- Warwick Medical School
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-10-01
- Primary completion
- 2011-10-01
- Enrollment
- 4000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.